Tevogen TVGN
NASDAQ TVGN
$6.53 -0.28 (-4.11%)
At close: Oct 23, 2026 · 4:00 PM EDT

Tevogen (TVGN) Non-Current Debt (2024 - 2026)

Updated

Tevogen (TVGN) recorded Non-Current Debt of $6.4 million in Q2 2026, up 45.5% from $4.4 million a year earlier and unchanged from the prior quarter.

Analysis

Tevogen (TVGN) Non-Current Debt (2024 - 2026) Analysis & Trends

At the end of FY2025, Tevogen reported Non-Current Debt of $4.4 million, up 340.0% from FY2024.

  • Across earlier years, Non-Current Debt came in at $1 million in FY2024.
  • On a year-over-year basis, Non-Current Debt has increased for three consecutive quarters.
  • Per Business Quant, the preceding three quarters came in at $6.4 million (Q1 2026), $4.4 million (Q4 2025) and $4.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 35.80 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 62.48 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 23.83 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 60.50 Bn
10 Tevogen 24.97 Mn 24.97 Mn - 6.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.40 Mn
Mar 31, 2026 6.40 Mn
Dec 31, 2025 4.40 Mn
Sep 30, 2025 4.40 Mn
Jun 30, 2025 4.40 Mn
Mar 31, 2025 3.00 Mn
Dec 31, 2024 1.00 Mn
API Access

Tevogen Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=TVGN&period=max&api_key=YOUR_API_KEY